Can Mark Cuban’s Low-Cost Drug Company Disrupt the Pharma Industry? | WSJ

Drug prices remain out of reach for many Americans, who pay among the highest prices in the world. In an interview with WSJ, billionaire investor Mark Cuban explains how his low-cost, online drug company works and the challenges it faces in a consolidated industry.

Share with Others
Categories

LISTING OWNER

Publish on other channels